Stem Cell News: Breaking Stem Cell News, Comments and Articles. - Page: 4

Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure

The Firm is actively filing lawsuits on behalf of alleged victims of metal-on-metal hip replacement failure, including DePuy ASR hip recall lawsuits, DePuy Pinnacle hip replacement lawsuits, Biomet hip implant lawsuits, Stryker hip recall lawsuits, and Wright hip implant lawsuits. New York, New York (PRWEB) May 20, 2013 The nationwide law firm of Bernstein Liebhard LLP notes that a new study has...

Human embryonic stem cells created via cloning

Embryonic stem cells have been created from human skin cells for the first time by US scientists using a cloning technique...

Germany’s G-BA Finds No Added Benefit For CTI’s Pixuvri, Exposing Price

Germany’s G-BA lets through Cell Therapeutics’ Pixuvri for aggressive B-cell non-Hodgkin's lymphoma but finds no added benefit over existing therapies, meaning its price could come under pressure.

Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering

Selexis’ co-founder and scientific advisory board member will present, “Engineering the CHO Genome for Improved Transgene Integration and Expression” Geneva, Switzerland (PRWEB) May 20, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today that the...

Ethical path to artificial stem cell technology

Australian research has created a molecular roadmap that shows how any cell in the human body can be turned into artificial stem cells. The roadmap, produced in collaboration with Harvard University, is a major advance in cellular reprogramming tec...

Scientists unite to solve mystery of mental illness and neurological conditions

Some of the UK’s leading neuroscientists, stem cell biologists, psychologists and psychiatrists are uniting to break down scientific barriers in a bid to solve the mystery of mental illness and neurological conditions. (Wellcome Trust)

MRPC Honored as Top Workplace by Milwaukee Journal Sentinel

Medical Device Manufacturer Receives Recognition for Second Consecutive Year. Butler, Wis. (PRWEB) May 20, 2013 Wisconsin-based MRPC, a single-source provider of medical device components and assemblies, has been recognized by the Milwaukee Journal Sentinel as a 2013 Top Workplace in Southeastern Wisconsin. For the second consecutive year, MRPC received the award honoring the best places to work...

MaxCyte Presents Unprecedented Data Using Flow Electroporation for CHO-Based Transient Gene Expression to Achieve Gram Scale Antibody Production and Rapid Stable Cell Line Generation

Transient Gene Expression (TGE) Method Reporting Over 1 Gram/Liter Antibody Titers to be Presented at IBC’s 9th Annual Cell Line Development & Engineering Conference MaxCyte, Inc., the pioneer in scalable, high performance cell transfection systems, is hosting a series of events at IBC’s 9th Annual Cell Line Development & Engineering Confer...

X-ray method shows how frog embryos could help thwart disease

An international team of scientists using a new X-ray method recorded the internal structure and cell movement inside a living frog embryo in greater detail than ever before.Read more about X-ray method shows how frog embryos could help

Acetylon Pharmaceuticals to Present at UBS Global Healthcare Conference

Acetylon Pharmaceuticals Inc., the leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced that Walter C. Ogier, President and Chief Executive Officer of Acetylon, will present at the UBS Global Healthcare Conference today, May 20, 2013, at 1:00 p.m. ET in New York City in the Riverside South room at...

BioTime CEO Dr. Michael West to Present at USC Minisymposium: Musculoskeletal Development and Repair

BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at the USC Minisymposium: Musculoskeletal Development and Repair conference at the Keck School of Medicine, the University of Southern California, on...

Advanced Cell Technology (ACTC.OB) Better vision after treatments

    Clinical trial participant showed vision improvement from 20/400 to 20/40   The vision of a patient enrolled in a clinical investigation of the retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) has imp...

World Stem Cells & Regenerative Medicine Congress Live Blogs and Twitter

Are you at the World Stem Cells and Regenerative Medicine Congress 2013? If you are, we hope you are enjoying your time here. But even [...]

GE Scientists in Technology “Relay Race” Against Cancer

GE technologies being developed to impact every stage of cancer patient care from screening to treatment and monitoring Earlier detection, more precise diagnosis, and enabling more effective treatments and monitoring all key goals in the race to defeat cancer To commemorate National Cancer Research Month, a team of...

DVS Sciences CyTOF® Mass Cytometer Featured in Paper Selected to Receive the Cytometry A 2012 Best Paper Award

DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research technology, today announced that its CyTOF® Mass Cytometer was used in an award winning paper. The paper, Single-Cell Mass Cytometry Adapted to Measurements of the Cell Cycle, published in Cytometry Part A (81A:552-56...

A Focus On Stem-Cell Therapy And Regenerative Medicine For 2013

By A John Hodge:In January, I wrote an article on regenerative medicine companies that could make headway in 2013. I would like to refocus on the subject and review some of my favorite candidates in the young, but quickly growing industry of regenerative medicine. The subject matter has worldwide appeal and relevance, as everyone on the planet can benefit from it. As a patient, regenerative medici...

BioRestorative Therapies Signs Agreement with Dexterity, Inc. to Advance Production of the Company's Novel brtxDISC™ Stem Cell Therapy Device

JUPITER, Fla., May 20, 2013  /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on developing stem cell based therapies for various personal applications, announces the signing of a consulting agreement with Dexterity, Inc. ("Dexterity"). Dexterity is a product design and bioengineering firm that will pro...

Sports Medicine New Frontiers: Platelet-Rich-Plasma (PRP) and Stem Cell Therapy

CLEARWATER, Fla., May 20, 2013 /PRNewswire/ -- Sports Medicine is always at the forefront of innovative medical technology.  Athletes are constantly striving to improve. Records are broken as humans run faster, jump higher, and strive for higher levels of performance. Athletes expose their bodies to more wear and tear as performance increases. Scientific training principles and diet have chan...

OrbusNeich's Genous™ Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients

HONG KONG, May 20, 2013 /PRNewswire/ -- OrbusNeich today announced that the company's Genous Stent is associated with a significantly lower rate of binary restenosis compared to bare metal stents (BMS) in low-risk non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients at six months. Data from JACK-EPC, an investigator-initiated randomized study, were published in the Ju...

Cord Blood America, Inc. Announces New Service Offering

SALT LAKE CITY, May 20, 2013 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced the launch of a new service offering for the storage of mesenchymal cells through its wholly owned subsidiary CorCell Companies, Inc. (CorCell). For additional information on the new service offering please visit our cord tissue web...

Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania

ROCKVILLE, Md., May 20, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported that Eva Feldman, MD, PhD, principal investigator, presented updated Phase I data from its spinal cord-derived human neural stem cell (NSI-566) trial in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) at the neuro diabetes special medical symposium in Bucharest,...

Vitamin D may help treat severe asthma

”Sunshine vitamin 'may treat asthma'”, BBC News informs us, as a new lab-based study suggests vitamin D could help control symptoms of severe asthma. Asthma is caused by inflammation of the airways, related to malfunctioning of the body’s immune system. In theory, the immune system mistakes harmless substances, such as dust mites, as a threat and triggers inflammation of the lungs and airwa...

Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering

Geneva, Switzerland (PRWEB) May 20, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today that the Comp...

Type 1 Diabetes May Be Reversible With Immune Suppressor Protein

A professor in Melbourne, Australia, who is on a mission to find a cure for type 1 diabetes, believes that the answer, or part of it, lies with an immune suppressor protein called CD52. And if it works for type 1 diabetes, then it may well work fo...

Mechanism linking key inflammatory marker to cancer identified

Researchers have revealed how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth.